Name Net increased
positions
Increased positions Reduced positions Return since
30 Sep ‘20
151
19 29 10 14.2%
152
19 59 40 110%
153
19 29 10 10.1%
RCUS icon
154
Arcus Biosciences
RCUS
$3.04B
19 56 37 43.3%
155
19 40 21 313%
156
18 45 27 21.3%
157
18 52 34 58.4%
158
18 152 134 2.14%
159
18 55 37 288%
160
18 150 132 93.4%
ACAD icon
161
Acadia Pharmaceuticals
ACAD
$4.54B
18 103 85 34.9%
162
18 49 31 95%
163
18 95 77 36.8%
164
18 47 29 15.2%
165
17 33 16 930%
166
17 44 27 39%
167
17 82 65 70.7%
168
17 48 31 498%
169
17 26 9 155%
170
17 116 99 6.96%
171
17 40 23 399%
172
17 47 30 578%
173
16 50 34 352%
174
16 16 0 97.8%
175
16 16 0 11.9%